Leukemia Research
Volume 24, Issue 7 , Pages 553-558 , July 2000

The EVI-1 gene — its role in pathogenesis of human leukemias

Received 1 January 2000 ,Accepted 16 February 2000.

References 

  1. Morishita K, Parganas E, Willman C, Whittaker M, Drabkin H, Oval J, et al. Activation of EVI-1 gene expression in human acute myelogenous leukemias by translocations spanning 300–400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci USA. 1992;89:3937
  2. Nucifora G. The EVI-1 gene in myeloid leukemia. Leukemia. 1997;11:2022
  3. Morishita K, Suzukawa K, Taki T, Ihle J, Yakota J. EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN128CTCATCTTC. Oncogene. 1995;10:1961
  4. Bartholomew C, Ihle JN. Retroviral insertions 90 kilobases proximal to the EVI-1 myeloid transforming gene activate transcription from the normal promoter. Mol. Cell. Biol. April 1991: 1820.
  5. Matsugi T, Morishita K, Ihle J. Identification, nuclear localization and DNA-binding activity of the zinc finger protein encoded by the EVI-1 myeloid transforming gene. Mol. Cell. Biol. Mar. 1990: 1259.
  6. Ogawa S, Kurokawa M, Tanaka T, Hangaishi A, Mitani K, Kamada N, et al. Increased EVI-1 expression is frequently observed in blast crisis of chronic myelocytic leukemia. Leukemia. 1996;10:788
  7. Russell M, Thompson F, Spier C, Taetle R. Expression of the EVI-1 gene in chronic myelogenous leukemia in blast crisis. Leukemia. 1993;7(10):1654
  8. Suzukawa K, Taki T, Abe T, Asoh H, Kamada N, Yokota J, et al. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI-1 gene in two cases of CML-BC with inv(3)(q21q26). Genomics. 1997;42:356
  9. Morishita K, Parganas E, Douglass EC, Ihle J. Unique expression of the human EVI-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternately spliced transcripts. Oncogene. 1990;5:963
  10. Bartholomew C, Clark AM. Induction of two alternatively spliced Evi-1 proto-oncogene transcripts by cAMP in kidney cells. Oncogene. 1994;9:939
  11. Perkins AS, Fishel R, Jenkins NA, Copeland NG. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol. Cell. Biol. May 1991: 2665.
  12. Xi ZF, Russell M, Woodward S, Thompson F, Wagner L, Taetle R. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia. Leukemia. 1997;11:212
  13. Funabiki T, Kreider BL, Ihle J. The carboxyl domain of zinc fingers of the EVI-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG. Oncogene. 1994;9:1575
  14. Bordereaux D, Fichelson S, Tambourin P, Gisselbrecht S. Alternative splicing of the EVI-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs. Oncogene. 1990;5:925
  15. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26; q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 1994;13(3):504
  16. Okada H, Watanabe T, Niki M, Takano H, Chiba N, Yanai N, et al. AML1 (−/−) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene. 1998;17:2287
  17. Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H. Dual functions of the AML1/EVI-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol. May 1995: 2383.
  18. Fears S, Mathieu C, Zeleznik-Le N, Huang S, Rowley JD. Intergenic splicing of MDS1 and EVI-1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc. Natl. Acad. Sci. USA. 1996;93:1642
  19. Wimmer K, Vinatzer U, Zwirn P, Fonatsch C, Wieser R. Comparative expression analysis of the antagonistic transcription factors Evi-1 and MDS1-Evi1 in murine tissues and during in vitro hematopoietic differentiation. Biochem. Biophys. Res. Commun. 1998;252:691
  20. Soderholm J, Kobayashi H, Mathieu C, Rowley JD, Nucifora G. The leukemia-associated gene MDS1/EVI-1 is a new type of GATA-binding transactivator. Leukemia. 1997;11:352
  21. Matsugi T, Kreider BL, Delwel R, Cleveland JL, Askew DS, Ihle JN. The EVI-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences. Oncogene. 1995;11:191
  22. Bartholomew C, Kilbey A, Clark AM, Walker M. The EVI-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation. Oncogene. 1997;14:569
  23. Pekarsky Y, Rynditch A, Wieser R, Fonatsch C, Gardiner K. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia. Cancer Res. 1997;57:3914
  24. Ohyashiki K, Ohyashiki JH, Fujieda H, Shimamoto T, Kawakubo K, Nakazawa S, et al. EVI-1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia. Leukemia. 1994;8(12):2169
  25. Felischman EW, Volkova MA, Fenkel MA, Konstantinowa LN, Kulagina OE, Bavonov AE, et al. Translocation (2;3)(p13;q26) in two cases of myeloid malignancies: acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia. Cancer Genet. Cytogenet. 1996;87:182
  26. Levaltier X, Penther D, Bastard C, Troussard X. T(2;3)(q23;p26) in a patient with AML M2. Br. J. Haematol. 1996;94:1027
  27. Kwong YL, Chan LC, Lie KW. T(2;3)(p13;q26) in a case of chronic myeloid leukemia. Importance of the involvement of 3q26. Cancer Genet. Cytogenet. 1992;59:95
  28. Desangles F, Vilain E, Arborio M, De Revel T, Flandrin G. T(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse. Leuk. Lymphoma. 1995;19:184
  29. Asou H, Suzukawa K, Kita K, Nakase K, Ueda H, Morishita K, et al. Establishment of a undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI-1 gene. Jpn. J. Cancer Res. 1996;87:269
  30. Mugneret F, Solary E, Favre B, Caillot D, Sidaner I, Guy H. New case of t(3;17)(q26;q22) as an additional change in a Philadelphia positive chronic myelogenous leukemian acceleration. Cancer Genet. Cytogenet. 1992;60:90
  31. Yu Fu Y, Sadamura S, Ishikura H, Abe Y, Katsuno M, Nishimura J, et al. Expression of EVI-1 and the retinoblastoma genes in acute myelogenous leukemia with t(3;13)(q26;q13-14). Am. J. Hematol. 1996;53:30
  32. Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, et al. Expression of EVI-1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood. 1994;84(4):1243
  33. Privitera E, Longoni D, Brambillasca F, Biondi A. EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML). Leukemia. 1997;11:2045
  34. Morishita K, Parganas E, Parham DM, Matsugi T, Ihle JN. The EVI-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene. 1990;5:1419
  35. Hamaguchi H, Suzukawa K, Nagata K, Yamamoto K, Yagasaki F, Morishita K. Establishment of a novel human myeloid leukemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI-1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Br. J. Haematol. 1997;98:399
  36. Dreyfus F, Bouscary D, Melle J, Ribrag V, Guesnu M, Varet B. Expression of the EVI-1 gene in myelodysplastic syndromes. Leukemia. 1995;9:203
  37. Ohyashiki K, Ohyashiki JH, Shimamoto T, Toyama K. Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI-1 in leukemia and myelodysplastic syndromes. Leuk. Lymphoma. 1996;23:431
  38. Ogawa S, Kurokawa M, Tanaka T, Mitani K, Inazawa J, Hangaishi A, et al. Structurally altered EVI-1 protein generated in the 3q21q26 syndrome. Oncogene. 1996;13:183
  39. Igarashi T, Shimizu S, Morishita K, Ohtsu T, Itoh K, Minami H, et al. Acute myelogenous leukemia with monosomy 7, inv(3)(q21q26), involving activated EVI-1 gene occuring after a complete remission of lymphoblastic lymphoma: a case report. Jpn. J. Clin. Oncol. 1998;28(11):688
  40. Fontenay-Roupie M, Bouscary D, Melle J, Viguie F, Picard F, Guesnu M, et al. Expression of the transcription factor EVI-1 in human erythroleukemia cell lines and in leukemias. Hematol. Cell Ther. 1997;39:5
  41. Rath AV, Schmahl GE, Niemeyer CM. Expression of transcription factors during sodium phenylacetate induced erythroid differentiation in K562 cells. Blood Cells Mol. Dis. January 31 1997;23(2):27
  42. Oval J, Smedsrud M, Taetle R. Expression and regulation of the EVI-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1. Leukemia. 1992;6(5):446
  43. Kilbey A, Bartholomew C. EVI-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblast. Oncogene. 1998;16:2287

PII: S0145-2126(00)00031-X

Leukemia Research
Volume 24, Issue 7 , Pages 553-558 , July 2000

Article Tools

* Image Usage & Resolution